Resources
Download this reportCombating Malaria
Inside this issue
• Climate change could lead to the Andes becoming a hotspot
• Experts warn that eradication may be a distraction
• Vaccines face a big test - -
Content
World’s best chance to tackle killer
Determination and funds are growing but victory is far from certain, explains Andrew Jack
Control: Chasing elimination could undermine control
Critics warn that eradication may be a distraction, writes Andrew Jack
Related content and features
Interactive
Interactive map: Where malaria bites hardest
More than 40 per cent of the world’s population is at risk from malaria concentrated in the warmest and poorest parts of the world
Video: Africa development slowed by disease
Malaria is more than just a human human tragedy
External links
A list of organisations closely involved in the battle against malaria around the world
Video
Video: Eradication is achievable in 4-5 decades
But reality should temper ambition
Video: Funds give science a boost against parasite
Professor Brain Greenwood discusses the scientific advancements
Video: US pledges continued support to tackle malaria
Focus on the beneficiaries rather than the logos
Video: Business is key to eliminating malaria
Eradication will be down to good management
Leading-edge science: Robot researchers join a war on many fronts
New drugs and fresh approaches are being pursued, says Clive Cookson
Funding: Credit crisis spurs fiscal innovation
Governments and aid bodies are growing more inventive, reports Andrew Jack
Subsidy: High-level aid helps direct patients to better treatment
Giving money to drug manufacturers is controversial, says Andrew Jack
Guest column: Lives will be sacrificed if we lose momentum
An open and keen mind could lead those who oversee public assets to an unexpected candidate – eliminating deaths from malaria, writes Ray Chambers
Treatments: Vaccines face first big test
Many rivals are in earlier stages of development, says Clive Cookson
Treatment: Lack of profit slows progress on drugs
Non-profit bodies can offer another model, reports Andrew Jack
Spraying: Traditional mainstay may be reinvigorated
It is effective but expensive and is crying out for new ingredients, reports Ross Tieman
Business: Companies bring skills to the long campaign
Corporations have discovered a double dose of benefits, writes Sarah Murray
How Kenya stumbled
Poor hospital supplies forced patients to buy anti-malarial drugs on the private market
Diagnostics: More focused diagnosis could cut illness and death
Salamander Davoudi explains the need for a new generation of tests
